Back to News
MGI and AddLife AB: A Strategic Collaboration to Revolutionize Life Science in the Nordic Region
Jun 9, 2023
Share
MGI and AddLife AB: A Strategic Collaboration to Revolutionize Life Science in the Nordic Region
Stockholm, Sweden, 8 June 2023 - MGI Tech Co. Ltd. ("MGI"), a global leader in life science technology, is thrilled to announce a strategic collaboration with AddLife AB, one of Europe's largest distributors of clinical testing and laboratory equipment. This partnership aims to significantly enhance the distribution of MGI's cutting-edge products* in the Nordic region, leveraging the expertise and market presence of AddLife AB's Triolab Group subsidiaries, and expanding into innovative fields such as point-of-care testing (POCT) and remote ultrasound.
The Power of Partnership: MGI and AddLife AB
Under the agreement, AddLife AB's four Triolab Group subsidiaries, namely Triolab Sweden, Triolab Norway, Triolab Denmark (Iceland), and Triolab Finland will serve as separate distributors for MGI's innovative products*. This partnership represents a significant milestone in the life science industry, combining the strengths of two industry leaders to meet the evolving needs of healthcare providers in the Nordic region.
A Shared Vision for Innovation and Excellence
"At AddLife, we aim to meet all our customers' needs at the highest level. Innovation is one of our core values and the addition of the product line from MGI is a perfect complement to our laboratory portfolio in that respect. It gives our customers the possibility to use the most modern and innovative technology.", Kai Rantanen, Head of the Diagnostic Business at AddLife AB said.
MGI's Commitment to Advancing Life Science
Duncan Yu, President of MGI, also shared his thoughts on the collaboration, stating, "We are thrilled to partner with AddLife AB and its Triolab Group subsidiaries to expand our reach in the Nordic region. The extensive distribution network and market expertise of AddLife AB, combined with MGI's leading-edge sequencing products*, will enable us to effectively meet the needs of healthcare professionals and contribute to improved patient outcomes.”
A Milestone in Healthcare Innovation
The collaboration between MGI and AddLife AB represents a significant milestone in responding to the evolving needs of healthcare providers in the Nordic region. By combining their respective strengths and expertise, both companies aim to accelerate the adoption of cutting-edge sequencing technologies and promote improved patient care across the region.
About AddLife
AddLife is an independent European provider in life science that offers high quality products, services and consulting to both the private and public sectors. AddLife has about 2,200 employees in around 85 operating subsidiaries, which operate under their own brands. The Group has annual sales of approximately SEK 9 billion. AddLife is listed on the Nasdaq Stockholm stock exchange.
About MGI
MGI Tech Co., Ltd. (MGI) is committed to building core tools and technology to lead life science through intelligent innovation. Based on its proprietary technology, MGI focuses on research & development, production, and sales of sequencing instruments***, reagents***, and related products to support life science research, agriculture, precision medicine, and healthcare. MGI's mission is to develop and promote advanced life science tools for future healthcare. As of December 2021, MGI has a footprint that spans across more than 80 countries and regions, serves over 1,300 international users, and employs more than 2,050 professionals globally, around 35% of which are R&D personnel. For more information, please visit the MG About MGI MGI Tech Co., Ltd. (MGI) is committed to building core tools and technology to lead life science through intelligent innovation. Based on its proprietary technology, MGI focuses on research & development, production, and sales of sequencing instruments***, reagents***, and related products to support life science research, agriculture, precision medicine, and healthcare. MGI's mission is to develop and promote advanced life science tools for future healthcare. As of December 2021, MGI has a footprint that spans across more than 80 countries and regions, serves over 1,300 international users, and employs more than 2,050 professionals globally, around 35% of which are R&D personnel. For more information, please visit the mgi-tech.eu or connect on Twitter, LinkedIn, or YouTube. or connect on Twitter, LinkedIn, or YouTube.
MGI TECH CO., LTD.
LIFE SCIENCE INNOVATION
ADDLIFE AB
GENE SEQUENCING
TRIOLAB GROUP
Share